Jabra Enhance Select 500 vs Lexie B3

The Jabra Enhance Select 500 is a premium behind-the-ear OTC hearing aid priced at $1,995 that earns an A grade with a SoundScore of 4.2/5 in our lab testing. This places it in the top 18% of the OTC hearing aid category, ranking #13 among 65 tested devices. In our testing, speech clarity in quiet environments stands out as a key strength, scoring 4.3/5—a strong result that measures 1.50 points above the category average. Feedback handling is excellent at 4.6/5, ensuring stable performance during everyday movements. Music streaming quality scores 2.9/5, which is 0.98 points above the category average but only mixed in absolute terms. The device shows some limitations worth noting. Speech understanding in noisy environments scores 1.8/5, which is above the category average by 0.31 points but low in absolute terms—a common challenge across OTC devices. Own-voice comfort scores 2.2/5, falling 0.31 points below the category average, which may be noticeable for users sensitive to how their own voice sounds. This two-time Expert's Choice Award winner (2023, 2024) offers rechargeable batteries and streaming compatibility with both iPhone and Android devices, including hands-free calling. Consumers seeking similar sound quality at a lower price point may want to compare the Jabra Enhance Select 300 or Lucid Engage. The Enhance Select 500 is best suited for those prioritizing strong speech clarity in quieter settings and reliable streaming performance within the premium OTC segment.

The Lexie B3 is a mid-priced OTC hearing aid available at $999 that achieves an A grade with a SoundScore of 4.7/5 in our lab testing, ranking #1 among 65 OTC hearing aid devices tested. This behind-the-ear style device delivers category-leading performance across multiple metrics. Speech clarity is a standout strength. In our lab testing, the Lexie B3 scores an excellent 4.5/5 for speech in quiet, measuring 1.73 points above the OTC category average. Speech in noise performance scores 2.5/5—above the category average by 1.02 points, though only mixed in absolute terms at 2.5/5. This pattern reflects the broader challenge OTC devices face in noisy environments while still positioning the B3 as a top performer relative to its category. Music streaming quality is solid at 3.3/5, outperforming the category average by 1.38 points. Own-voice comfort scores a solid 3.0/5, sitting 0.49 points above average. Feedback handling is excellent at 4.6/5, essentially matching the already-strong category average. The Lexie B3 is best suited for consumers seeking top-tier OTC sound performance without prescription hearing aid costs. Those who prioritize speech clarity in quieter settings will find particular value here. Budget-conscious shoppers may want to consider alternatives like the RxEars Rxi, which offers strong performance at a lower price point.